JP2021501788A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021501788A5 JP2021501788A5 JP2020524826A JP2020524826A JP2021501788A5 JP 2021501788 A5 JP2021501788 A5 JP 2021501788A5 JP 2020524826 A JP2020524826 A JP 2020524826A JP 2020524826 A JP2020524826 A JP 2020524826A JP 2021501788 A5 JP2021501788 A5 JP 2021501788A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- formula
- halo
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- AMBAWAHKHZZAAY-UHFFFAOYSA-N CCC(C)c1c(C)cccc1 Chemical compound CCC(C)c1c(C)cccc1 AMBAWAHKHZZAAY-UHFFFAOYSA-N 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762580740P | 2017-11-02 | 2017-11-02 | |
| US62/580,740 | 2017-11-02 | ||
| US201862643074P | 2018-03-14 | 2018-03-14 | |
| US62/643,074 | 2018-03-14 | ||
| PCT/US2018/058969 WO2019090085A1 (en) | 2017-11-02 | 2018-11-02 | Modulators of the integrated stress pathway |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021501788A JP2021501788A (ja) | 2021-01-21 |
| JP2021501788A5 true JP2021501788A5 (enExample) | 2021-12-09 |
Family
ID=64572459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524826A Pending JP2021501788A (ja) | 2017-11-02 | 2018-11-02 | 統合的ストレス経路の調節剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20210169892A1 (enExample) |
| EP (1) | EP3704090B1 (enExample) |
| JP (1) | JP2021501788A (enExample) |
| KR (1) | KR20200096226A (enExample) |
| CN (1) | CN112218850A (enExample) |
| AU (2) | AU2018360853B2 (enExample) |
| BR (1) | BR112020008830A2 (enExample) |
| CA (1) | CA3080968A1 (enExample) |
| IL (1) | IL274405A (enExample) |
| MX (1) | MX2020004558A (enExample) |
| SG (1) | SG11202004018VA (enExample) |
| TW (1) | TWI813596B (enExample) |
| UY (1) | UY37958A (enExample) |
| WO (1) | WO2019090085A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110730777A (zh) * | 2017-06-07 | 2020-01-24 | 葛兰素史密斯克莱知识产权发展有限公司 | 作为atf4通路抑制剂的化学化合物 |
| IL301709B2 (en) | 2017-08-09 | 2025-07-01 | Denali Therapeutics Inc | Compounds, compositions and methods |
| TW201920129A (zh) | 2017-09-01 | 2019-06-01 | 美商戴納立製藥公司 | 化合物、組合物及方法 |
| JP2021501785A (ja) | 2017-11-02 | 2021-01-21 | カリコ ライフ サイエンシーズ エルエルシー | 統合的ストレス経路の調節剤 |
| JP2021508336A (ja) | 2017-12-13 | 2021-03-04 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路の阻害剤 |
| US11166942B2 (en) | 2018-06-05 | 2021-11-09 | Praxis Biotech LLC | Inhibitors of integrated stress response pathway |
| TW202545902A (zh) | 2018-10-11 | 2025-12-01 | 美商嘉來克生命科學有限責任公司 | 整合應激路徑之前藥調節劑 |
| CR20210426A (es) | 2019-02-13 | 2021-09-30 | Denali Therapeutics Inc | Compuestos, composiciones y métodos |
| EP3924341A4 (en) | 2019-02-13 | 2022-11-02 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| WO2020216766A1 (en) | 2019-04-23 | 2020-10-29 | Evotec International Gmbh | Modulators of the integrated stress response pathway |
| MX2021012904A (es) | 2019-04-23 | 2022-01-18 | Evotec Int Gmbh | Moduladores de la via de respuesta al estres integrada. |
| AR118836A1 (es) * | 2019-04-30 | 2021-11-03 | Calico Life Sciences Llc | Moduladores de la vía de tensión integrada |
| PH12021552759A1 (en) * | 2019-04-30 | 2022-07-04 | Abbvie Inc | Substituted cycloalkyls as modulators of the integrated stress pathway |
| JP2022536663A (ja) | 2019-06-12 | 2022-08-18 | プラクシス バイオテック エルエルシー | 統合的ストレス応答経路のモジュレーター |
| CA3162526A1 (en) | 2020-01-28 | 2021-08-05 | Christopher John Brown | Modulators of the integrated stress response pathway |
| KR20220151635A (ko) | 2020-03-11 | 2022-11-15 | 에보텍 인터내셔널 게엠베하 | 통합 스트레스 반응 경로의 조절제 |
| MX2023004677A (es) | 2020-10-22 | 2023-05-24 | Evotec Int Gmbh | Moduladores de la via de respuesta integrada al estres. |
| ES2997335T3 (en) | 2020-10-22 | 2025-02-17 | Evotec Int Gmbh | Modulators of the integrated stress response pathway |
| CA3195290A1 (en) | 2020-10-22 | 2022-04-28 | Holly Victoria Atton | Modulators of the integrated stress response pathway |
| CN117580824A (zh) * | 2020-10-30 | 2024-02-20 | 卡里科生命科学有限责任公司 | 整合应激通路的调节剂 |
| EP4237413A1 (en) * | 2020-10-30 | 2023-09-06 | Calico Life Sciences LLC | Modulators of the integrated stress pathway |
| TW202241857A (zh) | 2020-12-18 | 2022-11-01 | 美商戴納立製藥公司 | 化合物之固體形式 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| DK0495421T3 (da) | 1991-01-15 | 1996-12-09 | Alcon Lab Inc | Anvendelse af carragenaner i topiske ophthalmiske sammensætninger |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| WO2014144952A2 (en) * | 2013-03-15 | 2014-09-18 | Peter Walter | Modulators of the eif2alpha pathway |
| TW201808903A (zh) * | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TWI920577B (zh) * | 2016-05-05 | 2026-04-01 | 美商嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TW201808888A (zh) * | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| CN110730777A (zh) * | 2017-06-07 | 2020-01-24 | 葛兰素史密斯克莱知识产权发展有限公司 | 作为atf4通路抑制剂的化学化合物 |
-
2018
- 2018-11-01 UY UY0001037958A patent/UY37958A/es not_active Application Discontinuation
- 2018-11-02 US US16/761,354 patent/US20210169892A1/en not_active Abandoned
- 2018-11-02 MX MX2020004558A patent/MX2020004558A/es unknown
- 2018-11-02 KR KR1020207015793A patent/KR20200096226A/ko not_active Ceased
- 2018-11-02 EP EP18812425.9A patent/EP3704090B1/en active Active
- 2018-11-02 CA CA3080968A patent/CA3080968A1/en active Pending
- 2018-11-02 TW TW107138980A patent/TWI813596B/zh active
- 2018-11-02 SG SG11202004018VA patent/SG11202004018VA/en unknown
- 2018-11-02 JP JP2020524826A patent/JP2021501788A/ja active Pending
- 2018-11-02 CN CN201880085190.8A patent/CN112218850A/zh active Pending
- 2018-11-02 BR BR112020008830-7A patent/BR112020008830A2/pt not_active Application Discontinuation
- 2018-11-02 AU AU2018360853A patent/AU2018360853B2/en not_active Expired - Fee Related
- 2018-11-02 WO PCT/US2018/058969 patent/WO2019090085A1/en not_active Ceased
-
2020
- 2020-05-03 IL IL274405A patent/IL274405A/en unknown
-
2023
- 2023-06-20 AU AU2023203860A patent/AU2023203860B2/en active Active
- 2023-09-07 US US18/463,183 patent/US20240000792A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021501785A5 (enExample) | ||
| JP2021501780A5 (enExample) | ||
| JP2021501786A5 (enExample) | ||
| JP2021501787A5 (enExample) | ||
| JP2021501789A5 (enExample) | ||
| JP2021501781A5 (enExample) | ||
| JP2021501790A5 (enExample) | ||
| JP2021501779A5 (enExample) | ||
| JP2022530647A5 (enExample) | ||
| RU2020117900A (ru) | Модуляторы интегрированного стресса | |
| WO2024040080A1 (en) | Kras inhibitor conjugates | |
| CN106459076B (zh) | 用于诱导软骨发生的化合物和组合物 | |
| RU2020117927A (ru) | Модуляторы интегрированного стресса | |
| JP7819118B2 (ja) | 短鎖デヒドロゲナーゼ活性を調節する組成物及び方法 | |
| CN103214484A (zh) | 作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶 | |
| JP2015501134A5 (enExample) | ||
| JP2022530647A (ja) | 統合的ストレス経路の置換シクロアルキルモジュレーター | |
| EP3852533A1 (en) | Pyridazinones and methods of use thereof | |
| EA037416B1 (ru) | Слитый белок для обезболивания и/или профилактики возникновения боли | |
| US10864203B2 (en) | Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer | |
| WO2019079649A1 (en) | SUBSTITUTED PYRROLOPYRIDINES AS INHIBITORS OF ACTIVIN RECEPTOR-RELATED KINASE | |
| CN116940386A (zh) | 吡咯并苯并二氮杂䓬-抗体缀合物以及其用途 | |
| EP3976009A2 (en) | Bax inhibitors and uses thereof | |
| JP2025519540A (ja) | Ｐｉ３ｋ阻害剤としてのベンゾピリミジン－４（３ｈ）－オン | |
| WO2023192642A2 (en) | Methods and compounds for modulating huntington's disease |